These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2910559)

  • 41. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions.
    Liam CK; Lim KH; Wong CM
    Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of vascular endothelial growth factor (VEGF) in neoplastic and tuberculosis effusions--preliminary results].
    Jankowska R; Porebska I; Dyła T
    Pneumonol Alergol Pol; 2002; 70(5-6):258-64. PubMed ID: 12518624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnostic value of pleural fluid cytologic examination].
    Zablockis R; Nargela R
    Medicina (Kaunas); 2002; 38(12):1171-8. PubMed ID: 12552157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of two strategies for the interpretation of tumour markers in pleural effusions.
    Trapé J; Sant F; Franquesa J; Montesinos J; Arnau A; Sala M; Bernadich O; Martín E; Perich D; Pérez C; Lopez J; Ros S; Esteve E; Pérez R; Aligué J; Gurt G; Catot S; Domenech M; Bosch J; Badal JM; Bonet M; Molina R; Ordeig J
    Respir Res; 2017 May; 18(1):103. PubMed ID: 28545517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ofloxacin concentrations in serum, saliva and pleural effusion of patients with pulmonary tuberculosis and lung cancer.
    Miya T; Hamakubo S; Goya T; Hanaoka T; Hosaka K
    Jpn J Antibiot; 1995 Jul; 48(7):960-4. PubMed ID: 7563589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of pleural effusions in acute pulmonary embolism: radiological and pleural fluid data from 230 patients.
    Porcel JM; Madroñero AB; Pardina M; Vives M; Esquerda A; Light RW
    Respirology; 2007 Mar; 12(2):234-9. PubMed ID: 17298456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Presence of high-molecular-weight forms and domain alterations of fibronectin in pleural effusion of patients with lung cancer.
    Pupek M; Krzyzanowska-Gołab D; Dyła T; Lemańska-Perek A; Jankowska R; Katnik-Prastowska I
    Clin Biochem; 2009 May; 42(7-8):654-61. PubMed ID: 19161998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic Utility Of Pleural Fluid Adenosine Deaminase Level In Tuberculous Pleural Effusion.
    Suleman A; Kamal M; Abbasi MA
    J Ayub Med Coll Abbottabad; 2016; 28(2):245-248. PubMed ID: 28718554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum and pleural fluid selenium, copper, zinc, and magnesium levels in malignant and nonmalignant pleural diseases.
    Tekşen F; Mungan D; Sayal A; Misurligil Z; Aydin A; Gürbüz L; Işimer A; Demirel YS; Acican T; Sin B
    Respiration; 1996; 63(1):25-7. PubMed ID: 8833989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical diagnostic utility of adenosine deaminase, interferon-γ, interferon-γ-induced protein of 10 kDa, and dipeptidyl peptidase 4 levels in tuberculous pleural effusions.
    Wang H; Yue J; Yang J; Gao R; Liu J
    Heart Lung; 2012; 41(1):70-5. PubMed ID: 21917315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders.
    Werle B; Sauckel K; Nathanson CM; Bjarnadottir M; Spiess E; Ebert W; Abrahamson M
    Biol Chem; 2003 Feb; 384(2):281-7. PubMed ID: 12675521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholesterol in pleural effusions. A diagnostic aid.
    Hamm H; Brohan U; Bohmer R; Missmahl HP
    Chest; 1987 Aug; 92(2):296-302. PubMed ID: 3608600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions.
    Garcia-Pachon E; Padilla-Navas I; Dosda MD; Miralles-Llopis A
    Chest; 1997 Mar; 111(3):643-7. PubMed ID: 9118701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The serum-effusion albumin gradient in the evaluation of pleural effusions.
    Roth BJ; O'Meara TF; Cragun WH
    Chest; 1990 Sep; 98(3):546-9. PubMed ID: 2152757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
    Ni SS; Gao ZL
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measurement of lactic acid in pleural fluid.
    Brook I
    Respiration; 1980; 40(6):344-8. PubMed ID: 7221202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic value of suPAR in differentiating noncardiac pleural effusions from cardiac pleural effusions.
    Ozsu S; Oztuna F; Mentese A; Abul Y; Ozlu T
    Clin Respir J; 2016 Jan; 10(1):61-6. PubMed ID: 25043397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcription expression and clinical significance of dishevelled-3 mRNA and δ-catenin mRNA in pleural effusions from patients with lung cancer.
    Li XY; Liu SL; Cha N; Zhao YJ; Wang SC; Li WN; Wang EH; Wu GP
    Clin Dev Immunol; 2012; 2012():904946. PubMed ID: 22461838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.